89Zr-trastuzumab PET/CT for prediction of response to HER2-targeted therapy in patients with HER2 mutant lung cancer: An exploratory phase 2 trial Meeting Abstract
| Authors: | Ulaner, G.; Offin, M.; Scaltriti, M.; Myers, M.; Venkatesh, A.; Panora, E.; Kris, M.; Rudin, C.; Arcila, M.; Lyashchenko, S.; Lewis, J.; Li, B. |
| Abstract Title: | 89Zr-trastuzumab PET/CT for prediction of response to HER2-targeted therapy in patients with HER2 mutant lung cancer: An exploratory phase 2 trial |
| Meeting Title: | 2019 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) |
| Journal Title: | Journal of Nuclear Medicine |
| Volume: | 60 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Jun 22-25 |
| Meeting Location: | Anaheim, CA |
| ISSN: | 0161-5505 |
| Publisher: | Society of Nuclear Medicine |
| Date Published: | 2019-05-01 |
| Language: | English |
| ACCESSION: | WOS:000473116800144 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 144 -- Source: Wos |
